secwatch / observer
8-K filed February 6, 2024, 6:59 PM ET ticker KNTK CIK 0001692787
leadership confidence high sentiment neutral materiality 0.20

Director Ronald Schweizer resigns; ISQ designates Michael A. Kumar as replacement

Kinetik Holdings Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Ronald Schweizer

director
KNTK · Kinetik Holdings Inc.
Effective
2024-02-05
Successor
Michael A. Kumar
Filed
February 6, 2024, 6:59 PM ET
On February 5, 2024, Ronald Schweizer notified the Board of Directors (the “ Board ”) of Kinetik Holdings Inc. (the “ Company ”) that he would be resigning as a member of the Board, effective immediately.
Appointed

Michael A. Kumar

director
KNTK · Kinetik Holdings Inc.
Effective
2024-02-05
Filed
February 6, 2024, 6:59 PM ET
On February 5, 2024, the Board appointed Michael A. Kumar to serve as a director of the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ronald Schweizer resigned as director at Kinetik Holdings Inc..

Action
resigned
Role
director
Exact text from the filing
On February 5, 2024, Ronald Schweizer notified the Board of Directors (the “ Board ”) of Kinetik Holdings Inc. (the “ Company ”) that he would be resigning as a member of the Board, effective immediately.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Michael A. Kumar was appointed as director at Kinetik Holdings Inc..

Action
appointed
Role
director
Exact text from the filing
On February 5, 2024, the Board appointed Michael A. Kumar to serve as a director of the Board, effective immediately.
View on SEC.gov

Kinetik Holdings Inc. filing history →

Source: SEC EDGAR
accession 0001193125-24-025252
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.